BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1379685)

  • 1. Decreased electrophilicity of chemicals carcinogenic only at the maximum tolerated dose.
    Rosenkranz HS; Klopman G
    Mutat Res; 1992 Aug; 282(4):241-6. PubMed ID: 1379685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the potential carcinogenicity and genetic toxicity to humans of the herbicide acetochlor.
    Ashby J; Kier L; Wilson AG; Green T; Lefevre PA; Tinwell H; Willis GA; Heydens WF; Clapp MJ
    Hum Exp Toxicol; 1996 Sep; 15(9):702-35. PubMed ID: 8880207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents.
    Rosenkranz HS; Klopman G
    Environ Mol Mutagen; 1993; 21(2):193-206. PubMed ID: 8444146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
    Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
    Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the report: correlation between carcinogenic potency and the maximum tolerated dose: implications for risk assessment.
    Krewski D; Gaylor DW; Soms AP; Szyszkowicz M
    Risk Anal; 1993 Aug; 13(4):383-98. PubMed ID: 8234946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary estimates of the virtually safe dose for tumors obtained from the maximum tolerated dose.
    Gaylor DW
    Regul Toxicol Pharmacol; 1989 Apr; 9(2):101-8. PubMed ID: 2717786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nongenotoxic carcinogens: an extension of the perspective provided by Perera.
    Ashby J; Purchase IF
    Environ Health Perspect; 1992 Nov; 98():223-6. PubMed ID: 1486853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.
    Venkatapathy R; Wang CY; Bruce RM; Moudgal C
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):209-21. PubMed ID: 18977375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of the association between maximum-tolerated dose and carcinogenicity in 326 long-term studies in rats and mice.
    Haseman JK; Seilkop SK
    Fundam Appl Toxicol; 1992 Aug; 19(2):207-13. PubMed ID: 1516777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
    Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
    Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP.
    Ashby J; Tennant RW
    Mutat Res; 1991 May; 257(3):229-306. PubMed ID: 1707500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the carcinogenic potential of the herbicide alachlor to man.
    Heydens WF; Wilson AG; Kier LD; Lau H; Thake DC; Martens MA
    Hum Exp Toxicol; 1999 Jun; 18(6):363-91. PubMed ID: 10413243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.